Effect of gender and obesity on postprandial lipemia in non-diabetic normolipidemic subjects and subjects with familial combined hyperlipidemia;Efecto del género y de la obesidad en la lipemia postprandial en sujetos sanos normolipidémicos no diabéticos y sujetos con hiperlipemia familiar combinada

Revista Clinica Espanola

Volumn 206, Issue 5, 2006, Pages 213-219

  Bartual, A ^a   Gonzalez C ^a   Martinez Hervas S ^a   Real, J T ^a   Garcia Garcia A B ^a   Castro Cabezas, M ^b   Chaves, F J ^a   Priego, M A ^a   Ascaso, J F ^a   Carmena, R ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Diurnal capillary triglycerides; Familial combined hyperlipidemia; Obesity; Postprandial lipemia

Indexed keywords

TRIACYLGLYCEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MALE; OBESITY; POSTPRANDIAL STATE; SELF EXAMINATION; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

EID: 33745684291     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13088559     Document Type: Article

References (28)

1. Austin MA, Hokanson JE. The epidemiologic case for triglyceride as a risk factor for rardiovascular disease. Atheroclerosis. 1998;81(4A):18B-25B.
2. Kuo PT, Carson JC. Dietary fats and the diurnal serum triglyceride levels in man. J Clin Invest. 1959;38:1384-93.
3. Miller M, Seidler A, Moalemi A, Pearson TA. Normal triglyceride levels and coronary artery disease events: The Baltimore coronary observational long-term study. JACC. 1998;31:1252-7.
4. Halkes CJM, van Dijk H, de Jaegere PPTh, Plokker HWM, Erkelens DW, Castro Cabezas M. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease. Effects of expanded dose simvastatin. Arterioscler Thromb Vasc Biol. 2001;21:1526-30.
5. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473-85.
6. Weintraub MS, Grosskopf I, Bassin T, Miller H, Charach G, Rotmensch HH, et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ. 1996; 312:935-9.
7. Meyer E, Westerveld HT, de Ruyter-Heijstek FC, van Greevenbroek MMJ, Rienks R, van Rijn HJM, et al. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case control study. Atherosclerosis. 1996; 124:221-35.
8. Proctor SD, Mamo JCL. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall evidence that plaque cholesterol may be derived from postprandial lipoproteins. Eur J Clin Invest. 1998;28:497-503.
9. Castro Cabezas M, Halkes CJM, Meijsson S, van Oostrom AJHHM, Erkelens DW. Diurnal triglyceride profiles: a novel approach to study triglyceride changes. Atherosclerosis. 2001;155:219-28.
10. Delawi D, Meijssen S, Castro Cabezas M. Intraindividual variation of fasting plasma lipids, apolipoproteins and postprandial lipemia in familial combined hyperlipidemia. Clin Chim Acta. 2003;328:139-45.
11. Gotto AM, Amarenco P, Assmann G, Carmena R, Davignon J, Frucuart JC, et al. The ILIB Lipid Handbook: Introduction. En: Gotto AM, Assmann G, Carmena R, et al. editors. The ILIB lipid handbook for clinical practice. New york: International Lipid Information Bureau; 2000. p. 1-30.
12. Castro Cabezas M, de Bruin TW, de Valk HM, Shoulders CC, Jansen H, Erkelens W. Impaired fatty acid metabolism in familial combined hyperlipemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest. 1993;92:160-8.
13. Verseyden C, Meijssen S, Castro Cabezas M. Postprandial changes of apo B-100 and apo B-48 in TG rich lipoproteins in familial combined hyperlipidemia. J Lipid Res. 2002;43:274-80.
14. Castro Cabezas M, de Brain TWA, Jansen H, Kock LAW, Kortland W, Erkelens DW. Impaired chylomicron remmants clearance in familial combined hyperlipidemia. Arterioscler Thromb. 1993;13:804-14.
15. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5.
16. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583-95.
17. Havel RJ, Eder HJ, Bragdon JH. The distribution and chemical composition of centrifugally separated lipoproteins in human serum. Eur J Clin Invest. 1955;34:1345-53.
18. Rosseneu M, Vercaemst R, Steinberg KK, Cooper GR. Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem. 1983;29:427-33.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
20. Halkes CJ, Castro Cabezas M, van Wijk JP, Erkelens DW. Gender diferences in diurnal triglyceridemia in lean and overweight subjects. Int J Obes Relat Metab Disord. 2001;25:1767-74.
21. Westerveld HE. Estrogens and postprandial metabolism. Atherosclerosis. 1998;141:105-7.
22. Halkes CJ, van Dijk H, Verseyden C, de Jaegere PP, Plokker HW, Meijssen S, et al. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2003;23:1875-80.
23. Ascaso JF, Merchante A, Lorente RI, Real JT, Martínez-Valls J, Carmena R. A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients. Metabolism. 1998: 47:1-7.
24. Ascaso JF, Real JT, Merchante A, Rodrigo A, Carmena R. Lipoprotein phenotype in familial combined hyperlipidemia. Metabolism. 2000;49: 1627-31.
25. Real JT, Ascaso JF, Carmena R. Insulin resistance and familial combined hyperlipidemia. Cardiovasc risk factors. 1999;3:101-6.
26. Blackburn P, Lamarche B, Couillard C, Pascot A, Bergeron N, Prud'homme D, et al. Postprandial hyperlipidemia: another correlate of the «hypertriglyceridemic waist» phenotype in men. Atherosclerosis. 2003;171: 327-36.
27. Ascaso JF, Sales J, Merchante A, Real J, Lorente R, Martínez-Valls J, et al. Influence of obesity on plasma lipoproteins, glicemia and insulinemia in patients with familial combined hiperlipidemia. Int J Obes Relat Metab Disord. 1997;108:530-3.
28. Halkes CJ, Van Wijk JP, Ribalta J, Masana L, Castro Cabezas M. Diurnal triglyceridaemia and insulin resistance in mildly obese subjects with normal fasting plasma lipids J Intern Med. 2004;255:74-81.